Margaret W. Crane

Medical Writer with Eclectic Tendencies

With 20 years' experience as a writer and editor for academic and non-profit organizations, I specialize in translating complex research issues into lively, readable prose for lay audiences. I also love writing profiles and human-interest stories across a variety of fields and settings. My clients and employers have included Weill Cornell Medical College, the New York Academy of Sciences, NYU Medical Center, the Crohn's & Colitis Foundation, and the Paul & Daisy Soros Fellowships for New Americans, among others. My work has appeared in The Scientist, the Los Angeles Times, and on numerous health and education websites. I also delight in working with individual authors as a ghost-writer, collaborator, and editor.

Portfolio

Feature Articles

Bridging the patient-physician divide
In the decades after his initial diagnosis with psoriatic disease, Brandon Kee, now 44, has lived, worked and coped with multiple, overlapping disorders requiring the care of an...
September Is National Recovery Month - Sovereign Health Group
By Margaret W. Crane As F. Scott Fitzgerald famously wrote in The Great Gatsby, "Life starts all over again when it gets crisp in the fall." Most of us welcome that feeling of a...
An Old Treatment Approach Offers New Option to Eczema Patients | National Eczema Association
In 2008, Dr. Richard Aron, an established pediatric dermatologist in London and Cape Town, South Africa, hung out his electronic shingle, offering his own topical treatment for...
NPF researcher identifies microRNA with major potential
Roughly defined, RNA relays instructions between genes and proteins, telling our cells which proteins to build and how to build them. According to Dr. Enikö Sonkoly, senior...
Molecular chain reaction drives skin injury and psoriasis
NPF-funded discovery pinpoints possible target for psoriasis treatment
Living the Questions
Profile of a physician/scientist and alumnus of the Paul & Daisy Soros Fellowships for New Americans program
The Brain Institute (4 short articles)
A second biologic drug for eczema makes its way to market | National Eczema Association
Following on the heels of Dupixent (dupilumab)-the first-ever biologic drug for atopic dermatitis (the most common type of eczema), approved by the U.S. Food and Drug...
Urbanization: Environmental Catastrophe or New Global Ecology?
Fertility and IBD: What Men Need to Know
Don't ignore cardiovascular risk, researcher urges
NPF-funded study signals urgent need for screening guidelines for people with psoriatic arthritis.
Where Endoscopists Boldly Go
Genetic Discovery: Getting Up to Speed
IBD and Delayed Growth: A Twin Affliction
In the Tracks of Virulent Herpes Simplex
Heat and the City
Anti-Angiogenic Research Approaches Advance Alternatives in Treating Cancers

Newsletters

Responding to the World Trade Center Disaster
Special issue of NYU Medical Center's internal newsletter
Inflammation: The Common Thread
Bacterial Skin Infections in Children
NYU Medical Center's Dermatology Newsletter

Nutrition Column for the Crohn's & Colitis Foundation

How Sweet It Is!
The Skinny on Fats: Choose Wisely
Building Strong Bones and Health Bodies: Not by Bread Alone
Nutrition column for patients with Crohn's disease or ulcerative colitis

Miscellany

The Church of Saint Charles Borromeo
Celebrating the 125th anniversary of a historic black Catholic church in Harlem
Planting the Seeds for Health Equity Around the World
Research Report

All Copyrights Belong To Their Respective Owners